SCHEMBL3819862

SCHEMBL3819862

CC(c1nc2ccc(C(N)=O)cc2c(=O)n1C)N1CCN(S(=O)(=O)c2ccc(Cl)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.45
▸ CNR1 P21554 8/20 0.45
▸ CTDSP1 Q9GZU7 1/20 0.43
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ CNR2 P34972 3/20 0.40
▸ ATM Q13315 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ POLB P06746 2/20 0.39
▸ GBA1 P04062 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3820231 0.91 ALDH1A1 (0.40) LMNAHTTMAPK1SMN1; SMN2GBA1
SCHEMBL3820236 0.90 CFTR (0.45) KMT2APOLBGBA1MEN1
SCHEMBL13723945 0.87 ATM (0.43) CTDSP1LMNAHTTUSP2TSHR
SCHEMBL3825309 0.86 ATM (0.44) S1PR1CTDSP1LMNAHTTUSP2
SCHEMBL3821683 0.85 GBA1 (0.44) CTDSP1LMNAHTTUSP2TSHR
SCHEMBL15457299 0.85 GBA1 (0.47) HTTSMN1; SMN2KMT2AGBA1
SCHEMBL15457091 0.84 LMNA (0.47) CTDSP1LMNAHTTUSP2TSHR
SCHEMBL15457123 0.84 HTT (0.45) LMNAHTTUSP2TSHRMAPK1
SCHEMBL15457180 0.84 S1PR1 (0.46) S1PR1CNR1CTDSP1LMNAHTT
SCHEMBL15457092 0.84 PKM (0.43) CTDSP1LMNAHTTUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 — — EP disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 — — EP disclosed
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters CFTR, ABCB1, ABCC2 S1PR1 2071/4885CNR1 1450/4885CTDSP1 2781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback